These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 11513178
1. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W, Austrian Inflammatory Bowel Diseases Study Group. Am J Gastroenterol; 2001 Aug; 96(8):2382-7. PubMed ID: 11513178 [Abstract] [Full Text] [Related]
2. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906 [Abstract] [Full Text] [Related]
3. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study. Krafft A, Breymann C. J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035 [Abstract] [Full Text] [Related]
4. Response of hemoglobin, serum ferritin, and serum transferrin receptor during iron supplementation in pregnancy: a prospective study. Madhavan Nair K, Bhaskaram P, Balakrishna N, Ravinder P, Sesikeran B. Nutrition; 2004 Oct; 20(10):896-9. PubMed ID: 15474878 [Abstract] [Full Text] [Related]
5. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Bailie GR. Arzneimittelforschung; 2010 Oct; 60(6a):386-98. PubMed ID: 20648930 [Abstract] [Full Text] [Related]
6. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease. Voudoukis E, Karmiris K, Oustamanolakis P, Theodoropoulou A, Sfiridaki A, Paspatis GA, Koutroubakis IE. Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158 [Abstract] [Full Text] [Related]
8. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC, Hung SC, Tarng DC. Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [Abstract] [Full Text] [Related]
9. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC. Am J Hematol; 2011 Nov; 86(11):923-7. PubMed ID: 21812017 [Abstract] [Full Text] [Related]
12. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE, Lombraña A, Duarte P, Di Gennaro F. J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147 [Abstract] [Full Text] [Related]
20. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H, Wang SX. Blood Purif; 2008 Oct 23; 26(2):151-6. PubMed ID: 18212498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]